Depressive symptoms in Parkinson’s disease are insufficiently but more often treated than in other chronic conditions

EPIPARK Study Group

doi:10.1038/s41531-023-00551-8

Depressive symptoms in Parkinson’s disease are insufficiently but more often treated than in other chronic conditions

EPIPARK Study Group

Segeberger Kliniken

Abstract

Depressive symptoms in Parkinson’s disease (PD) are multifactorial and are partly linked to the underlying dopaminergic deficit. However, at least a subset of PD patients may exhibit an unspecific depressive reaction to chronic illness. Here, we compared the prevalence and severity of depressive symptoms in PD patients and disease controls (DC). PD patients reported depressive symptoms at similar frequencies as DC but were on antidepressants, especially Mirtazapine, more frequently. Still, in both groups, a high proportion of patients with clinically significant depressive symptoms was not receiving medication. Diagnosis and treatment of depressive symptoms both in PD and DC should be improved.

Original language	English
Article number	113
Journal	NPJ Parkinson's disease
Volume	9
Issue number	1
ISSN	2373-8057
DOIs	https://doi.org/10.1038/s41531-023-00551-8
Publication status	Published - 12.2023

Research Areas and Centers

Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

DFG Research Classification Scheme

206-07 Clinical Neurology Neurosurgery and Neuroradiology
206-08 Cognitive and Systemic Human Neuroscience
206-10 Clinical Psychiatry, Psychotherapy amd Paediatric and Juvenile Psychiatrie

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41531-023-00551-8

Cite this

@article{ce9ea0ee88044ed3a06bb9cddcc2ac60,

title = "Depressive symptoms in Parkinson{\textquoteright}s disease are insufficiently but more often treated than in other chronic conditions",

abstract = "Depressive symptoms in Parkinson{\textquoteright}s disease (PD) are multifactorial and are partly linked to the underlying dopaminergic deficit. However, at least a subset of PD patients may exhibit an unspecific depressive reaction to chronic illness. Here, we compared the prevalence and severity of depressive symptoms in PD patients and disease controls (DC). PD patients reported depressive symptoms at similar frequencies as DC but were on antidepressants, especially Mirtazapine, more frequently. Still, in both groups, a high proportion of patients with clinically significant depressive symptoms was not receiving medication. Diagnosis and treatment of depressive symptoms both in PD and DC should be improved.",

author = "{EPIPARK Study Group} and Tatiana Usnich and Bj{\"o}rn Hauptmann and Henrike Hanssen and Jannik Prasuhn and Alexander Balck and Max Borsche and Vera Tadic and Annika Klee and Greta Noblejas-Sanchez and Vollstedt, {Eva Juliane} and Christine Klein and Norbert Br{\"u}ggemann and Meike Kasten and Julia Graf and Nathalie Schell and Raluca Modreanu and Barbara Staemmler and Elena Loewin",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1038/s41531-023-00551-8",

language = "English",

volume = "9",

journal = "NPJ Parkinson's disease",

issn = "2373-8057",

number = "1",

}

TY - JOUR

T1 - Depressive symptoms in Parkinson’s disease are insufficiently but more often treated than in other chronic conditions

AU - EPIPARK Study Group

AU - Usnich, Tatiana

AU - Hauptmann, Björn

AU - Hanssen, Henrike

AU - Prasuhn, Jannik

AU - Balck, Alexander

AU - Borsche, Max

AU - Tadic, Vera

AU - Klee, Annika

AU - Noblejas-Sanchez, Greta

AU - Vollstedt, Eva Juliane

AU - Klein, Christine

AU - Brüggemann, Norbert

AU - Kasten, Meike

AU - Graf, Julia

AU - Schell, Nathalie

AU - Modreanu, Raluca

AU - Staemmler, Barbara

AU - Loewin, Elena

PY - 2023/12

Y1 - 2023/12

N2 - Depressive symptoms in Parkinson’s disease (PD) are multifactorial and are partly linked to the underlying dopaminergic deficit. However, at least a subset of PD patients may exhibit an unspecific depressive reaction to chronic illness. Here, we compared the prevalence and severity of depressive symptoms in PD patients and disease controls (DC). PD patients reported depressive symptoms at similar frequencies as DC but were on antidepressants, especially Mirtazapine, more frequently. Still, in both groups, a high proportion of patients with clinically significant depressive symptoms was not receiving medication. Diagnosis and treatment of depressive symptoms both in PD and DC should be improved.

AB - Depressive symptoms in Parkinson’s disease (PD) are multifactorial and are partly linked to the underlying dopaminergic deficit. However, at least a subset of PD patients may exhibit an unspecific depressive reaction to chronic illness. Here, we compared the prevalence and severity of depressive symptoms in PD patients and disease controls (DC). PD patients reported depressive symptoms at similar frequencies as DC but were on antidepressants, especially Mirtazapine, more frequently. Still, in both groups, a high proportion of patients with clinically significant depressive symptoms was not receiving medication. Diagnosis and treatment of depressive symptoms both in PD and DC should be improved.

UR - http://www.scopus.com/inward/record.url?scp=85165275208&partnerID=8YFLogxK

U2 - 10.1038/s41531-023-00551-8

DO - 10.1038/s41531-023-00551-8

M3 - Journal articles

AN - SCOPUS:85165275208

SN - 2373-8057

VL - 9

JO - NPJ Parkinson's disease

JF - NPJ Parkinson's disease

IS - 1

M1 - 113

ER -

Depressive symptoms in Parkinson’s disease are insufficiently but more often treated than in other chronic conditions

Abstract

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this